LeMaitre Vascular Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

LeMaitre Vascular şirketinin toplam hissedar öz sermayesi $331.1M ve toplam borcu $0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $377.0M ve $46.0M dir. LeMaitre Vascular 'in FAVÖK'ü $49.6M faiz karşılama oranı -11.5 dur. Şirketin $123.9M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

Borç/özkaynak oranı

US$0

Borç

Faiz karşılama oranı	-11.5x
Nakit	US$123.89m
Eşitlik	US$331.07m
Toplam yükümlülükler	US$45.95m
Toplam varlıklar	US$377.03m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: LHU 'nin kısa vadeli varlıkları ( $227.1M ) kısa vadeli yükümlülüklerini ( $29.3M ) aşıyor.

Uzun Vadeli Yükümlülükler: LHU şirketinin kısa vadeli varlıkları ( $227.1M ) uzun vadeli yükümlülüklerini ( $16.6M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: LHU borçsuzdur.

Borcun Azaltılması: LHU un 5 yıl önce borcu yoktu.

Borç Kapsamı: LHU un borcu yoktur, dolayısıyla işletme nakit akışı tarafından karşılanmasına gerek yoktur.

Faiz Kapsamı: LHU şirketinin borcu bulunmadığından faiz ödemelerinin karşılanması söz konusu değildir.

LeMaitre Vascular Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

Third quarter dividend of US$0.16 announced

Lemaitre Vascular, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ending December 31, 2024

Third quarter 2024 earnings released: EPS: US$0.50 (vs US$0.34 in 3Q 2023)

LeMaitre Vascular, Inc. to Report Q3, 2024 Results on Oct 31, 2024

Second quarter dividend of US$0.16 announced

LeMaitre Vascular, Inc. Approves Quarterly Dividend, Payable on August 29, 2024

Second quarter 2024 earnings released: EPS: US$0.53 (vs US$0.36 in 2Q 2023)

LeMaitre Vascular, Inc. to Report Q2, 2024 Results on Aug 01, 2024

First quarter dividend of US$0.16 announced

President & Director recently sold €353k worth of stock

First quarter 2024 earnings released: EPS: US$0.44 (vs US$0.27 in 1Q 2023)

LeMaitre Vascular, Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2024

LeMaitre Vascular, Inc. to Report Q1, 2024 Results on May 02, 2024

LeMaitre Vascular, Inc., Annual General Meeting, Jun 03, 2024

Chairman & CEO recently sold €6.4m worth of stock

Upcoming dividend of US$0.16 per share

Fourth quarter dividend of US$0.16 announced

LeMaitre Vascular, Inc. Provides Earnings Guidance for the First Quarter and Full Year 2024

Full year 2023 earnings released: EPS: US$1.36 (vs US$0.94 in FY 2022)

LeMaitre Vascular, Inc. (NasdaqGM:LMAT) announces an Equity Buyback for $50 million worth of its shares.

LeMaitre Vascular, Inc. to Report Q4, 2023 Results on Feb 27, 2024

Chairman & CEO recently sold €2.6m worth of stock

Upcoming dividend of US$0.14 per share at 1.1% yield

Third quarter 2023 earnings released: EPS: US$0.34 (vs US$0.25 in 3Q 2022)

LeMaitre Vascular, Inc. Approves Quarterly Dividend, Payable on November 30, 2023

Now 20% undervalued after recent price drop

LeMaitre Vascular, Inc. to Report Q3, 2023 Results on Nov 01, 2023

Investor sentiment deteriorates as stock falls 19%

Upcoming dividend of US$0.14 per share at 1.0% yield

LeMaitre Vascular, Inc. Provides Earnings Guidance for the Third Quarter Ending September 30, 2023, Fourth Quarter and Full Year Ending December 31, 2023

Second quarter 2023 earnings released: EPS: US$0.36 (vs US$0.16 in 2Q 2022)

LeMaitre Vascular, Inc. to Report Q2, 2023 Results on Aug 01, 2023

Chairman & CEO recently sold €411k worth of stock

Upcoming dividend of US$0.14 per share at 0.8% yield

President & Director recently sold €505k worth of stock

LeMaitre Vascular, Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2023

First quarter 2023 earnings released: EPS: US$0.27 (vs US$0.28 in 1Q 2022)

Insufficient new directors

Senior Vice President of Operations recently sold €308k worth of stock

Full year 2022 earnings released: EPS: US$0.94 (vs US$1.27 in FY 2021)

LeMaitre Vascular, Inc. to Report Q4, 2022 Results on Feb 23, 2023

Upcoming dividend of US$0.13 per share

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released: EPS: US$0.25 (vs US$0.30 in 3Q 2021)

LeMaitre Vascular, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2022

LeMaitre Vascular, Inc. to Report Q3, 2022 Results on Oct 27, 2022

Lemaitre Vascular, Inc. Appoints Martha Shadan as Director

Upcoming dividend of US$0.13 per share

CFO, Treasurer recently sold €146k worth of stock

CFO, Treasurer recently sold €146k worth of stock

Second quarter 2022 earnings released: EPS: US$0.16 (vs US$0.40 in 2Q 2021)

LeMaitre Vascular, Inc. Approves Quarterly Dividend, Payable on September 8, 2022

LeMaitre Vascular, Inc. to Report Q2, 2022 Results on Jul 28, 2022

Now 21% undervalued

First quarter 2022 earnings released: EPS: US$0.28 (vs US$0.29 in 1Q 2021)

LeMaitre Vascular, Inc. to Report Q1, 2022 Results on Apr 28, 2022

LeMaitre Vascular, Inc., Annual General Meeting, Jun 01, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

LeMaitre Vascular, Inc. Provides Earnings Guidance for the First Quarter and Full Year of 2022

LeMaitre Vascular, Inc. to Report Q4, 2021 Results on Feb 24, 2022

Now 22% undervalued after recent price drop

Now 21% undervalued after recent price drop

Upcoming dividend of US$0.11 per share

Third quarter 2021 earnings released: EPS US$0.30 (vs US$0.37 in 3Q 2020)

Upcoming dividend of US$0.11 per share

Second quarter 2021 earnings released: EPS US$0.40 (vs US$0.17 in 2Q 2020)

LeMaitre Vascular, Inc. has completed a Follow-on Equity Offering in the amount of $54.5 million.

LeMaitre Vascular, Inc.(NasdaqGM:LMAT) dropped from Russell 3000E Value Index

Upcoming dividend of US$0.11 per share

Chairman & CEO recently sold €2.4m worth of stock

First quarter 2021 earnings released: EPS US$0.29 (vs US$0.16 in 1Q 2020)

Lemaitre Vascular, Inc. Provides Earnings Guidance for the Second Quarter of 2021

Insider recently sold €1.0m worth of stock

Chairman & CEO recently sold €6.2m worth of stock

New 90-day high: €42.80